Clinical trial
Evaluation of CD8+ T Cell Activation and Infiltration Into Primary Breast Tumors Following Administration of a Peptide Vaccine
NCT00892567 is registered in ClinicalTrials.gov with Craig L Slingluff, Jr as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of CD8+ T Cell Activation and Infiltration Into Primary Breast Tumors Following Administration of a Peptide Vaccine
- Lead sponsor
- Craig L Slingluff, Jr
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 31, 2009
- Completion date
- February 29, 2012
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.